These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35028708)

  • 1. Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy.
    Ying C; Zhou Z; Dai J; Wang M; Xiang J; Sun D; Zhou X
    Inflamm Res; 2022 Feb; 71(2):191-204. PubMed ID: 35028708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
    Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
    FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
    Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
    Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
    Qiu YY; Tang LQ
    Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Selective NLRP3-Inflammasome Inhibitor CY-09 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3- inflammasome Activation.
    Yang M; Zhao L
    Curr Med Chem; 2023; 30(28):3261-3270. PubMed ID: 36154582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV ameliorates diabetic nephropathy in
    Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
    Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
    Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
    Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
    J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine].
    Wang WW; Han WB; Wan YG; Tu Y; Liu BH; Liu YL; Wu W; Yee HY; Fang QJ; Yao J
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):7-13. PubMed ID: 32237405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammasomes and Fibrosis.
    Zhang WJ; Chen SJ; Zhou SC; Wu SZ; Wang H
    Front Immunol; 2021; 12():643149. PubMed ID: 34177893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
    Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
    Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichomonas vaginalis induces IL-1β production in a human prostate epithelial cell line by activating the NLRP3 inflammasome via reactive oxygen species and potassium ion efflux.
    Gu NY; Kim JH; Han IH; Im SJ; Seo MY; Chung YH; Ryu JS
    Prostate; 2016 Jul; 76(10):885-96. PubMed ID: 26959386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dioscorea zingiberensis ameliorates diabetic nephropathy by inhibiting NLRP3 inflammasome and curbing the expression of p66Shc in high-fat diet/streptozotocin-induced diabetic mice.
    Ren C; Zhou X; Bao X; Zhang J; Tang J; Zhu Z; Zhang N; Bai Y; Xi Y; Zhang Q; Ma B
    J Pharm Pharmacol; 2021 Aug; 73(9):1218-1229. PubMed ID: 34061184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.